Portfolio

CARDIOR

Cardior is focused on the development and clinical validation of ncRNA therapeutics for patients with myocardial infarction and heart failure. Cardior aims to market its products in collaboration with a strategic pharma partner after clinical proof-of-concept (POC) data.

Info & Contact

Dr. Claudia Ulbrich
Web:
www.cardior.de

Address

Cardior Pharmaceuticals GmbH
Carl-Neuberg-Str. 1
30625 Hannover

In portfolio

03. May 2017